Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Advances in Biological Regulation|November 6, 2019
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cellsShaw M Akula, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation|May 4, 2019
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cellsShaw M Akula, Saverio Candido, Massimo Libra, et al.
Aging|March 23, 2011
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and agingLinda S Steelman, William H Chappell, Stephen L Abrams, et al.
Advances in Biological Regulation|March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticalsSaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Oncotarget|March 18, 2011
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human healthWilliam H Chappell, Linda S Steelman, Jacquelyn M Long, et al.
Oncotarget|July 23, 2014
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole M Davis, Melissa Sokolosky, Kristin Stadelman, et al.
The Lancet. Primary Care|June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trialMaciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Current Pharmaceutical Design|March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for TherapyLinda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
Oncotarget|March 5, 2013
Advances in targeting signal transduction pathwaysJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Journal of Clinical Medicine|July 2, 2021
Arguments against the Requirement of a Biological License Application for Human Pancreatic Islets: The Position Statement of the Islets for US Collaborative Presented during the FDA Advisory Committee MeetingPiotr Witkowski, Jon Odorico, Jordan Pyda, et al.
Pageof 26